Endoscout Produktkatalog

 

Embed or link this publication

Description

Endoscout Produktkatalog

Popular Pages


p. 1

Produktübersicht 2. Quartal 2016

[close]

p. 2

Wir sind Endoscout Online-Medizintechnik-Vertrieb und Abrechnungsservice. Endoscout, mit Firmensitz in Freiburg, ist ein neues individuelles lösungs-, und kundenorientiertes Unternehmen, welches international agiert und global vernetzt ist. Es ist uns wichtig komplexe Vorgänge aufzuschlüsseln, zu verstehen, Ziele zu definieren und sie entsprechend umzusetzen, jeweils individuell auf die Problemstellung abgestimmt. Endoscout besteht aus zwei verschieden Unternehmenssparten, die sich in Endodepot und Endotrade gliedern. Unser Produktangebot für die verschiedenen Behandlungsindikatoren: 2

[close]

p. 3

Inhaltsverzeichnis About Acrostak Across CTO OTW CTO - Balloon, Over The Wire Across CTO RX CTO -Balloon, Rapid Exchange Genie Drug Delivery Balloon Grip CTO Balloon 4 6 8 10 12 Oceanus 18 - PTA balloon dilatation catheter Oceanus 35 - PTA balloon dilatation catheter Essential - Paclitaxel-eluting coronary dilatation balloon catheter iVolution - Self-expanding nitinol stent system 49 51 55 59 63 68 69 About Alvimedica Inperia Advance ballonexpandierbarer Unterschenkelstent Isthmus Logic ballonexpandierbarer Beckenstent Radix2 ballonexpandierender Nierenstent Cre8 BTK ballonexpandierbarer Drug Eluting Unterschenkelstent Easy HiFlype selbtexpandierender Beckenstent Easy Flype selbtexpandierender Oberschenkelstent 14 16 18 restorer - CoCr peripheral stent system About St. Jude AMPLATZER Vascular Plug I, II IV 20 About TriReme Medical Chocolate Touch - Drug coated PTA Balloon Catheter Chocolate PTA - Balloon Catheter 72 74 76 22 24 26 About STENTYS STENTYS BTK - Self-Expanding Drug-Eluting Stent for Below the knee 78 79 About Morris Fish Device Verschlusssystem 28 29 About Contego Medical Paladin - CAROTID POST-DILATION BALLOON ® 82 83 About iVascular Luminor 18 - Paclitaxel-eluting peripheral dilatation balloon catheter Luminor 14/35 - Paclitaxeleluting peripheral dilatation balloon catheter Oceanus 14 - PTA balloon dilatation catheter 34 35 39 45 3

[close]

p. 4

About Acrostak Acrostak was founded in 2001 and its headquarters are based in Switzerland. Acrostak is specialized in the development, manufacturing and distribution of single use medical devices in the fields of interventional cardiology, interventional radiology and interventional oncology. Acrostak is committed to develop high-quality and innovative products and is investing extensively in high-tech equipment and R&D projects. Table of contents Across CTO OTW CTO - Balloon, Over The Wire Across CTO RX CTO -Balloon, Rapid Exchange Genie Drug Delivery Balloon Grip CTO-Balloon 6 8 10 12 4

[close]

p. 5

5

[close]

p. 6

by Acrostak ACROSS CTO TM OTW The world’’s smallest lesion entry profile Designed to cross the most challenging CTOs thanks to superior shaft technology. Outstanding Balloon performances •• •• •• •• The world’’s smallest lesion entry profile of 0.015’’’’ (0.38mm) Truly tapered tip with less than 2° inclination Unsurpassed material resistance with RBP of 17 atm Hydrolubric™™ coating for minimal friction and optimal trackability Folded Balloon <2° 4 mm Balloon Tip Lesion Entry Profile 0.015““ (0.38 mm) Guide Wire max. 0.014““ (0.36 mm) Hypotube shaft design •• Metallic hypotube with ultra thin shaft wall and extremely smooth surface  PUSH Hypotube  Provides extra push to penetrate very stiff occlusion caps Flexy shaft design •• Proximal shaft made out of flexible polymer material Competitor 1  Flexy Provides extra flexibility to navigate within very tortuous anatomies, often encountered in retrograde approach Competitor 2 FLEX 6 Devices for interventional applications Acrostak © ACROSTAK | All rights reserved.

[close]

p. 7

MM 0016-001 Rev. A (06)EN ACROSS CTOTM OTW (hypotube) Usable Length 150 cm max. 0.014““ (0.36 mm) Distal Shaft Length 47 cm 23 cm DD-LL 10 mm 2.6 F (0.87 mm) 3.5 F (1.16 mm) 2.8 F (0.95 mm) ACROSS CTOTM OTW flexy Usable Length 150 cm max. 0.014““ (0.36 mm) DD-LL 10 mm 2.25 F (0.74 mm) 3.5 F (1.16 mm) COMPLIANCE CHART Pressure (atm) Ø1.1 10/15/20 5 7 (709 kPa) 1.04 1.10N 1.13 1.16 1.20 1.23 1.28* 1.38 1.45 * Rated Burst Pressure. Do not exceed. Devices for interventional applications Acrostak Manufactured by: Acrostak (Schweiz) AG Stegackerstrasse 14 CH-8409 Winterthur SWITZERLAND info@acrostak.com Phone +41 52 233 95 51 Fax +41 52 233 95 50 Distributed by: N 9 11 (1115 kPa) 13 15 17 (1722 kPa) 19 21 Nominal Pressure Worldwide distribution by: Acrostak International Route de Malagnou 6 CH-1206 Geneva SWITZERLAND sales@acrostak.com Phone +41 22 347 68 70 Fax +41 22 347 68 71 ORDERING INFORMATION Reference no. Diameter (mm) Length (mm) www.acrostak.com ACROSS CTOTM OTW* Not authorised for sale in the U.S. 110100481 110150481 110200481 110100482 110150482 110200482 * Hypotube 1.1 1.1 1.1 1.1 1.1 1.1 10 15 20 10 15 20 ACROSS CTOTM OTW flexy 7

[close]

p. 8

by Acrostak ACROSS CTO TM RX The world’’s smallest lesion entry profile Designed to cross the most challenging Chronic Total Occlusion. Outstanding crossability •• ••  Lesion entry profile of 0.015’’’’ (0.38mm) Truly tapered tip with less than 2° inclination <2°  Lesion Entry Profile 0.015““ (0.38 mm) Minimize the risk of failure to cross a CTO lesion once the wire has reached the distal true lumen Folded Balloon 4 mm Balloon Tip Guide Wire max. 0.014““ (0.36 mm) Unsurpassed balloon strength •• ••  High pressure balloon with RBP up to 25 atm Ultra-resistant to puncture  Across CTO Lesion Entry Profile Rated Burst Pressure 0.015’’’’ 25 atm * 2nd best 0.016’’’’ 14 atm 3rd best 0.017’’’’ 14 atm Very robust balloon material, optimizing the success of dilating the often heavily calcified CTO lesions *(RBP of 17 atm for Ø 1.1mm) Excellent trackability and pushability •• •• •• ““Tongue”” technology design enhances transfer of strength from shaft to balloon area Hydrolubric™™ coating for minimal friction and optimal trackability Parallel Guide Wire Exit Port for optimal pushability 8 © ACROSTAK | All rights reserved. Devices for interventional applications Acrostak

[close]

p. 9

MM 0007-001 Rev. E (05)EN ACROSS CTOTM RX Usable Length 138 cm Distal Shaft Length 23 cm max. 0.014““ (0.36 mm) Shaft tapered DD-LL Balloon Length 2.25 F (0.74 mm) 2.6 F (0.87 mm) 2.5 F (0.83 mm) 1.9 F (0.65 mm) COMPLIANCE CHART Pressure (atm) Ø1.1 10/15/20 Ø1.5 10/15/20 Ø2.0 10/15/20 5 7 (709 kPa) 9 11 (1115 kPa) 13 1.04 1.10 N 1.40 1.43 1.47 1.50 N 1.55 1.60 1.65 1.69 1.73 1.76 1.80 1.84 * 1.82 1.88 1.94 2.00 N 2.07 2.13 2.18 2.22 2.25 2.29 2.32 * 2.35 1.13 1.16 1.20 1.23 1.28 1.38 1.45 * Devices for interventional applications Acrostak Manufactured by: Acrostak (Schweiz) AG Stegackerstrasse 14 CH-8409 Winterthur SWITZERLAND info@acrostak.com Phone +41 52 233 95 51 Fax +41 52 233 95 50 Distributed by: N 15 17 (1722 kPa) 19 21 Worldwide distribution by: Acrostak International Route de Malagnou 6 CH-1206 Geneva SWITZERLAND sales@acrostak.com Phone +41 22 347 68 70 Fax +41 22 347 68 71 23 25 (2533 kPa) 27 Nominal Pressure * Rated Burst Pressure. Do not exceed. ORDERING INFORMATION Reference no. Diameter (mm) Length (mm) www.acrostak.com ACROSS CTOTM RX 110100480 110150480 110200480 150100480 150150480 150200480 200100480 200150480 200200480 1.1 1.1 1.1 1.5 1.5 1.5 2.0 2.0 2.0 10 15 20 10 15 20 10 15 20 Not authorised for sale in the U.S. 9

[close]

p. 10

GENIE by Acrostak Catheter TM A local drug delivery catheter for anti-stenosis drug. The GENIE Catheter™ is a new «local drug delivery (LDD) catheter» designed to deliver various liquid therapeutic agents, such as paclitaxel, into the arteries. Using the GENIE Catheter™, Physicians have developed the concept of «GENIE Catheter™ Therapy» by exposing coronary arteries to low dose (10µM) of paclitaxel to prevent stenosis. This new approach has been described as a potential alternative/complement to Drug Eluting Stent (DES) in specific indications(a). As a device GENIE Catheter™ offers 5 key benefits: In applications where the risk of stenosis is high (i.e. bifurcations, long lesion, CTO, ISR etc…), or when there are medical or economical concerns about using DES, physicians can still achieve the benefits of a local pharmacological treatment by using GENIE Catheter™ whilst avoiding long term and expensive anti-platelet treatment. After animal trials(a), a clinical study has demonstrated the interest of this «GENIE Catheter™ Therapy»: «a limited exposure (during 120”) to liquid paclitaxel in coronary arteries is sufficient to inhibit the cell growth process of stenosis». «LOCAL TAX» study(b) was conducted by Dr. C. HERDEG at the University Hospital of Tuebingen, Germany, and involved 204 patients. It compares the use of BMS alone or with concomitant exposure to liquid paclitaxel delivered by the GENIE Catheter™, to a Taxus™ DES. «No adverse events and no late thrombosis have been reported». a b 1. The GENIE Catheter™ is safe. It delivers the drug without any polymer or additional coating. 2. The GENIE Catheter™ is efficient. Liquid drug can reach most of the vessel wall (not only on the struts of the stent). 3. The GENIE Catheter™ is versatile. One can treat a wide range of locations (the lesion, the stent edge, and the adjacent vessel segments, …) 4. The GENIE Catheter™ is «non-expensive». The same device can be used to treat different lesions during the same procedure. 5. The GENIE Catheter™ is «non-traumatic». This is a «passive» delivery system which avoids the vascular trauma of plaque crushing and stenting Design of the micro-holes directs the fluid flow parallel to the balloon shaft. Refer to Dr C. HERDEG publications Published in 4th quarter 2008 TM coating 10 © ACROSTAK | All rights reserved. Devices for interventional applications Acrostak

[close]

p. 11

MM 0009-001 Rev.B (19)EN GENIE CATHETERTM - TECHNICAL DRAWING Usable Length 138 cm Distal Shaft Length 23 cm Ø 2.5, 3.0 and 3.5 mm Treatment Length Ø 2.0 mm DD-LL Micro-holes located in distal head 22, 27, 31 mm 25, 30, 34 mm 2.6 F (0.87 mm) 2.5 F (0.83 mm) 1.9 F (0.65 mm) EXTENSIVE DRUG DELIVERY HOW IT WORKS 1. Pre-fill the “GENIE Catheter™” with drug solution and purge it. 2. 3. Deliver the “GENIE Catheter™” to the treatment area(c) Inflate the “GENIE Catheter™” up to 2 atm, directly with the drug solution. The 2 heads block the flow The chamber between the 2 heads is filled up with drug solution through micro-holes After limited exposure, deflate the “GENIE Catheter™” and move to another area or pull back GENIE Catheter™ Concept 4. 5. The GENIE Catheter™ is available in 3 diameters from 2.5 to 3.5 mm and lengths of 20, 24 and 28 mm. The on-going GENIE Catheter™ development program also includes devices of larger diameters/lengths for peripheral applications(c). c Devices for interventional applications Acrostak Manufactured by: Acrostak (Schweiz) AG Stegackerstrasse 14 CH-8409 Winterthur SWITZERLAND info@acrostak.com Phone +41 52 233 95 51 Fax +41 52 233 95 50 Distributed by: do not use this balloon for dilatation also refer to section 9.3 “preparation” of the IFU before using the catheter Worldwide distribution by: Acrostak International Route de Malagnou 6 CH-1206 Geneva SWITZERLAND sales@acrostak.com Phone +41 22 347 68 70 Fax +41 22 347 68 71 ORDERING INFORMATION Reference Diameter (mm) Length (mm) www.acrostak.com GENIE CatheterTM 250200320 250240320 250280320 300200320 300240320 300280320 350200320 350240320 350280320 2.5 2.5 2.5 3.0 3.0 3.0 3.5 3.5 3.5 20 24 28 20 24 28 20 24 28 Not authorised for sale in the U.S. 11

[close]

p. 12

GRIP by Acrostak TM Full control over slippery and calcified lesions Optimal for the treatment of intra-stent restenosis, heavily calcified lesions and for stent post-dilation. Unique Knobs Design •  4 lines of knobs on the surface of the balloon anchor the balloon to the lesion during balloon inflation  Reduced risk of dissection caused by balloon slippage at the stent margins of ISR, and in delicate areas such as bifurcations, ostial lesions, and short calcified lesions • 4 lines of knobs designed to crush the hard plaque remaining between the struts of the stent   Optimal plaque crushing for superior post-dilation Outstanding Material Strength • • • High pressure balloon with RBP of 22 atm for all sizes Ultra-resistant to puncture Truly tapered tip: short tip design for maximum push (GRIP™) long tip design for maximum trackability in tortuous anatomies (GRIP™TT)   Securely reach and dilate heavily calcified lesions without compromising crossability 12 © ACROSTAK | All rights reserved. Devices for interventional applications Acrostak

[close]

p. 13

MM 0015-001 Rev. A (52)EN GRIPTM Usable Length 138 cm Distal Shaft Length 24 cm Balloon Length max. 0.014“ (0.36 mm) DD-LL Balloon Diameter 2.6 F (0.87 mm) 2.5 F (0.83 mm) 1.9 F (0.65 mm) 4 knob lines on balloon, each line at 90° Balloon length 8mm: 3 knobs on each line Balloon lengths 12 and 16 mm: 4 knobs on each line GRIPTM TT Lesion Entry Profile 0.018“ (0.46 mm) Guide Wire max. 0.014“ (0.36 mm) <2° Folded Balloon 4 mm Balloon Tip COMPLIANCE CHART (GRIPTM & GRIPTM TT) Pressure (atm) 6 8 10 11 12 14 16 18 N Ø2.5 10/15/20 Ø3.0 10/15/20 Ø3.5 10/15/20 Ø4.0 10/15/20 2.30 2.37 2.45 (1115 kPa) 2.50 2.54 2.62 2.68 2.73 2.77 * 2.76 2.84 2.94 3.00 3.05 3.14 3.22 3.27 3.33 3.38 N 3.19 3.31 3.44 3.50 3.56 3.67 3.76 3.83 3.90 3.97 3.65 3.78 3.91 4.00 4.07 4.19 4.29 4.37 4.45 4.52 Devices for interventional applications Acrostak Manufactured by: Acrostak (Schweiz) AG Stegackerstrasse 14 CH-8409 Winterthur SWITZERLAND 20 22 (2229 kPa) 2.81 * Rated Burst Pressure - do not exceed Nominal Worldwide distribution by: Acrostak International Route de Malagnou 6 CH-1206 Geneva SWITZERLAND sales@acrostak.com Phone +41 22 347 68 70 Fax +41 22 347 68 71 ORDERING INFORMATION Reference no. Diameter (mm) Length (mm) GRIPTM info@acrostak.com Phone +41 52 233 95 51 Fax +41 52 233 95 50 Distributed by: GRIPTM TT 250080660 250120660 250160660 300080660 300120660 300160660 350080660 350120660 350160660 400080660 400120660 400160660 2.5 2.5 2.5 3.0 3.0 3.0 3.5 3.5 3.5 4.0 4.0 4.0 8 12 16 8 16 8 12 16 8 12 16 Not authorised for sale in the U.S. 250080340 250120340 250160340 300080340 300120340 300160340 350080340 350120340 350160340 400080340 400120340 400160340 www.acrostak.com 12 13

[close]

p. 14

About Alvimedica Alvimedica is a young, agile company devoted to developing minimally-invasive medical technologies for medical professionals looking for the next level of innovation in the operating room. We firmly believe that working closely with physicians is the best way to improve our product solutions and services; ‘co-creation’ in the interest of patients – that’s what shapes us as a company. We invite medical professionals to visit our Centers of Excellence in R&D in Turkey, Italy and the Netherlands, to present and discuss new treatment options. This approach results in a growing and innovative product portfolio for both endovascular and interventional cardiology. Our commitment to improving surgical procedures through innovation is driven by our sincere care for patients’ quality of life and our goal to positively impact clinical outcomes. As our motto says: we want to help physicians bring their patients ‘Back to Life!’ as soon as possible, and based on safe medical practices. We invite you to join us in our ambition to create the best medical devices for people around the globe. Table of contents Inperia Advance - ballonexpandierbarer Unterschenkelstent Isthmus Logic - ballonexpandierbarer Beckentent Radix2 - ballonexpandierbarer Nierenstent Cre8 BTK - ballonexpandierbarer Drug Eluting Unterschenkelstent Easy HiFlype - selbtexpandierender Beckenstent Easy Flype - selbtexpandierender Oberschenkelstent 16 18 20 22 24 26 14

[close]

p. 15

15

[close]

Comments

no comments yet